Clorox Company (The) (CLX) Shares Bought by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC raised its holdings in Clorox Company (The) (NYSE:CLX) by 2.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,148 shares of the company’s stock after buying an additional 828 shares during the period. Manning & Napier Advisors LLC’s holdings in Clorox Company (The) were worth $4,108,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new stake in Clorox Company (The) in the first quarter valued at approximately $104,000. Parkside Financial Bank & Trust increased its stake in shares of Clorox Company (The) by 3.8% during the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after purchasing an additional 29 shares during the period. Valley National Advisers Inc. increased its stake in shares of Clorox Company (The) by 0.6% during the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after purchasing an additional 5 shares during the period. Sun Life Financial INC increased its stake in shares of Clorox Company (The) by 10,344.4% during the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after purchasing an additional 931 shares during the period. Finally, Blue Chip Partners Inc. increased its stake in shares of Clorox Company (The) by 3.9% during the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares during the period. Hedge funds and other institutional investors own 72.74% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.truebluetribune.com/2017/11/20/clorox-company-the-clx-shares-bought-by-manning-napier-advisors-llc-2.html.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 41,293 shares of company stock worth $5,560,303. 1.00% of the stock is currently owned by company insiders.

A number of equities analysts have recently weighed in on the company. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 target price (up previously from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Zacks Investment Research lowered Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub lowered Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $128.72.

Clorox Company (CLX) traded down $1.03 during midday trading on Monday, hitting $133.51. The company had a trading volume of 633,100 shares, compared to its average volume of 815,117. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. Clorox Company has a 12 month low of $112.28 and a 12 month high of $141.76. The firm has a market cap of $17,214.59, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 3.64 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the business posted $1.36 EPS. Clorox Company (The)’s revenue for the quarter was up 4.0% on a year-over-year basis. equities research analysts anticipate that Clorox Company will post 5.58 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.52%. The ex-dividend date is Tuesday, January 23rd. Clorox Company (The)’s dividend payout ratio (DPR) is 61.88%.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply